18 related articles for article (PubMed ID: 27144826)
1. Modulation of sHLA-G, PD-1, and PD-L1 Expression in Cervical Lesions Following Imiquimod Treatment and Its Association with Treatment Success.
Cokan A; da Silva NCH; Kavalar R; But I; Pakiž M; Andrade de Oliveira S; Dos Santos Gomes FO; da Silva RS; Peixoto CA; Lucena-Silva N
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610950
[TBL] [Abstract][Full Text] [Related]
2. Expression of Stemness Markers in the Cervical Smear of Patients with Cervical Insufficiency.
Pittokopitou S; Mavrogianni D; Pergialiotis V; Pappa KI; Antsaklis P; Theodora M; Sindos M; Papapanagiotou A; Domali A; Stavros S; Drakakis P; Daskalakis G
Cells; 2023 Apr; 12(8):. PubMed ID: 37190092
[TBL] [Abstract][Full Text] [Related]
3. C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro.
Belcastro M; Miller MR; Flynn DC; Soisson AP
Gynecol Oncol; 2004 Feb; 92(2):660-8. PubMed ID: 14766263
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha?
Urosevic M; Oberholzer PA; Maier T; Hafner J; Laine E; Slade H; Benninghoff B; Burg G; Dummer R
Clin Cancer Res; 2004 Aug; 10(15):4959-70. PubMed ID: 15297396
[TBL] [Abstract][Full Text] [Related]
5. Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia.
Lin CT; Qiu JT; Wang CJ; Chang SD; Tang YH; Wu PJ; Jung SM; Huang CC; Chou HH; Jao MS; Lai CH
Taiwan J Obstet Gynecol; 2012 Dec; 51(4):533-8. PubMed ID: 23276555
[TBL] [Abstract][Full Text] [Related]
6. Preliminary stop of the TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC) trial.
Koeneman MM; Kruse AJ; Kooreman LF; Zur Hausen A; Hopman AH; Sep SJ; Van Gorp T; Slangen BF; van Beekhuizen HJ; van de Sande AJ; Gerestein CG; Nijman HW; Kruitwagen RF
BMC Cancer; 2017 Feb; 17(1):110. PubMed ID: 28173776
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of the treatment with imiquimod in persistent infection by human papillomavirus with the polimerase chain reaction method].
Hernández Quijano T; Illanes Aguiar B; Salas Linares N; Alarcón Romero Ldel C; Hernández Valencia M
Ginecol Obstet Mex; 2006 Jun; 74(6):317-26. PubMed ID: 16970118
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod treatment effectively reduces the percentage of viable cells in a cervical carcinoma cell line but does not affect the expression of HLA-G or OCT-4.
Stefanidis K; Patta J; Pergialiotis V; Stefanidi D; Loutradis D
J Stem Cells; 2015; 10(4):217-23. PubMed ID: 27144826
[TBL] [Abstract][Full Text] [Related]
9. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
